SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-400611
Filing Date
2014-11-06
Accepted
2014-11-06 14:03:15
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d787708d10q.htm 10-Q 279075
2 EX-31.1 d787708dex311.htm EX-31.1 5992
3 EX-31.2 d787708dex312.htm EX-31.2 6070
4 EX-32.1 d787708dex321.htm EX-32.1 4407
5 EX-32.2 d787708dex322.htm EX-32.2 4383
  Complete submission text file 0001193125-14-400611.txt   2851722

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ccxi-20140930.xml EX-101.INS 395870
7 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20140930.xsd EX-101.SCH 27904
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20140930_cal.xml EX-101.CAL 46626
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20140930_def.xml EX-101.DEF 71661
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20140930_lab.xml EX-101.LAB 237697
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20140930_pre.xml EX-101.PRE 167262
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 141200026
SIC: 2834 Pharmaceutical Preparations